rs745728411
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_004006.3(DMD):c.5449-12_5449-10delGTT variant causes a intron change. The variant allele was found at a frequency of 0.00018 in 1,207,286 control chromosomes in the GnomAD database, including 1 homozygotes. There are 63 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., 6 hem., cov: 22)
Exomes 𝑓: 0.00018 ( 1 hom. 57 hem. )
Consequence
DMD
NM_004006.3 intron
NM_004006.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.73
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-32346089-AAAC-A is Benign according to our data. Variant chrX-32346089-AAAC-A is described in ClinVar as [Likely_benign]. Clinvar id is 239607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.5449-12_5449-10delGTT | intron_variant | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.5449-12_5449-10delGTT | intron_variant | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes AF: 0.000170 AC: 19AN: 111727Hom.: 0 Cov.: 22 AF XY: 0.000177 AC XY: 6AN XY: 33939
GnomAD3 genomes
AF:
AC:
19
AN:
111727
Hom.:
Cov.:
22
AF XY:
AC XY:
6
AN XY:
33939
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000714 AC: 13AN: 182051Hom.: 0 AF XY: 0.0000597 AC XY: 4AN XY: 66955
GnomAD3 exomes
AF:
AC:
13
AN:
182051
Hom.:
AF XY:
AC XY:
4
AN XY:
66955
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000181 AC: 198AN: 1095559Hom.: 1 AF XY: 0.000158 AC XY: 57AN XY: 361763
GnomAD4 exome
AF:
AC:
198
AN:
1095559
Hom.:
AF XY:
AC XY:
57
AN XY:
361763
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000170 AC: 19AN: 111727Hom.: 0 Cov.: 22 AF XY: 0.000177 AC XY: 6AN XY: 33939
GnomAD4 genome
AF:
AC:
19
AN:
111727
Hom.:
Cov.:
22
AF XY:
AC XY:
6
AN XY:
33939
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 19, 2019 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 22, 2022 | See Variant Classification Assertion Criteria. - |
Duchenne muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 37
Find out detailed SpliceAI scores and Pangolin per-transcript scores at